Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 1008-1025
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.1008
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.1008
Figure 1 Flow chart of patient selection.
Fifteen hepatocellular carcinoma patients treated by associating liver partition and portal vein ligation for staged hepatectomy and 46 patients by right hemi-hepatectomy were included for analysis. ALPPS: Associating liver partition and portal vein ligation for staged hepatectomy; PSM: Propensity score matching.
- Citation: Wang W, Deng ZF, Wang JL, Zhang L, Bao L, Xu BH, Zhu H, Guo Y, Wen Z. Change of tumor-infiltrating lymphocyte of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma. World J Gastrointest Surg 2022; 14(9): 1008-1025
- URL: https://www.wjgnet.com/1948-9366/full/v14/i9/1008.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i9.1008